Jinlong Qi

361 East Zhongshan Road
Shijiazhuang, 050017, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Structure basis for the activation of KCNQ2 by endogenous and exogenous ligands.

Structure basis for the activation of KCNQ2 by endogenous and exogenous ligands.

Journal: Cell reports

Published: September 22, 2025

Metabolomic biomarkers discovery across chronic gastritis to gastric cancer progression.

Metabolomic biomarkers discovery across chronic gastritis to gastric cancer progression.

Journal: Scientific reports

Published: May 29, 2025

In Vivo/In vitro metabolic profiling and evaluation of key metabolites of QO-83, a novel KCNQ channel opener with antiepileptic potential.

In Vivo/In vitro metabolic profiling and evaluation of key metabolites of QO-83, a novel KCNQ channel opener with antiepileptic potential.

Journal: Biochemical pharmacology

Published: April 25, 2025

Traditional Chinese Medicine YangxinDingji alleviates arrhythmias through inhibition of sodium and L-type calcium channels.

Traditional Chinese Medicine YangxinDingji alleviates arrhythmias through inhibition of sodium and L-type calcium channels.

Journal: Journal of ethnopharmacology

Published: February 25, 2025

Neuroprotective Effects, Mechanisms of Action and Therapeutic Potential of the Kv7/KCNQ Channel Opener QO-83 in Ischemic Stroke.

Neuroprotective Effects, Mechanisms of Action and Therapeutic Potential of the Kv7/KCNQ Channel Opener QO-83 in Ischemic Stroke.

Journal: Translational stroke research

Published: August 23, 2024

A Novel Compound QO-83 Alleviates Acute and Chronic Epileptic Seizures in Rodents by Modulating KV7 Channel Activity.

A Novel Compound QO-83 Alleviates Acute and Chronic Epileptic Seizures in Rodents by Modulating KV7 Channel Activity.

Journal: CNS neuroscience & therapeutics

Published: August 01, 2024

The Kv4 potassium channel modulator NS5806 attenuates cardiac hypertrophy in vivo and in vitro.

The Kv4 potassium channel modulator NS5806 attenuates cardiac hypertrophy in vivo and in vitro.

Journal: Scientific reports

Published: January 19, 2024

A Review on the Role of TRP Channels and Their Potential as Drug Targets_An Insight Into the TRP Channel Drug Discovery Methodologies.

A Review on the Role of TRP Channels and Their Potential as Drug Targets_An Insight Into the TRP Channel Drug Discovery Methodologies.

Journal: Frontiers in pharmacology

Published: April 06, 2022

Multistage pH-responsive codelivery liposomal platform for synergistic cancer therapy.

Multistage pH-responsive codelivery liposomal platform for synergistic cancer therapy.

Journal: Journal of nanobiotechnology

Published: December 06, 2021

Molecular Mechanisms and Structural Basis of Retigabine Analogues in Regulating KCNQ2 Channel.

Molecular Mechanisms and Structural Basis of Retigabine Analogues in Regulating KCNQ2 Channel.

Journal: The Journal of membrane biology

Published: November 11, 2019

Entering the spotlight: Chitosan oligosaccharides as novel activators of CaCCs/TMEM16A.

Entering the spotlight: Chitosan oligosaccharides as novel activators of CaCCs/TMEM16A.

Journal: Pharmacological research

Published: February 27, 2019

Identification of Resveratrol, an Herbal Compound, as an Activator of the Calcium-Activated Chloride Channel, TMEM16A.

Identification of Resveratrol, an Herbal Compound, as an Activator of the Calcium-Activated Chloride Channel, TMEM16A.

Journal: The Journal of membrane biology

Published: December 16, 2016

Showing 1-12 of 18

Last Updated: 09/26/2026